NIKKEI 225
37,985.30 +356.82 (+0.95%) HANG SENG
17,595.75 +311.21 (+1.80%) CRUDE OIL
83.83 +0.26 (+0.31%) GOLD FUTURES
2,345.50 +3.00 (+0.13%) DOW
38,085.80 -375.12 (-0.98%) Bitcoin GBP
51,494.62 +80.82 (+0.16%)
United Health Products, Inc. (UEEC)
| Previous close | 0.1926 |
| Open | 0.2000 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's range | 0.1817 - 0.2000 |
| 52-week range | 0.1160 - 0.4500 |
| Volume | |
| Avg. volume | 145,069 |
| Market cap | 44.924M |
| Beta (5Y monthly) | -0.23 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.0100 |
| Earnings date | 08 May 2024 - 12 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GlobeNewswire
United Health Products Submits Full FDA PMA Application
MOUNT LAUREL, NJ, March 21, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- United Health Products, Inc. (OTCPK: UEEC) today provided an update on the company’s FDA Premarket Approval application process. The company confirms that it has submitted via the FDA eSTAR portal its Premarket Approval (PMA) application for its absorbable hemostatic gauze, which will now be reviewed by the FDA and Health Canada. Information on the FDA review process for PMA applications can be found on the FDA website at:
- GlobeNewswire
United Health Products Reports on FDA Application Status
MESQUITE, NV, Jan. 19, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – United Health Products (UEEC) reports today on the receipt and review of final reports on product sterilization and stability testing for its hemostatic gauze. As previously disclosed, UHP has been working with external packaging and sterilization service providers to complete various required tests for its Premarket Approval application. The reported data received this week on the efficacy of the proposed radiation sterilization
